Human Milk Oligosaccharides Market Expected to Reach USD 1,003.07 million and CAGR 22.4% by 2030

“According to the research report published by Polaris Market Research, the global human milk oligosaccharides market was valued at USD 189.66 million in 2021 and is expected to reach USD 1,003.07 million by 2030, to grow at a CAGR of 22.4% during the forecast period.”

Human Milk Oligosaccharides(HMO) are essential and inspiring elements of human milk and are the third most abundant solid component after lactose and lipids. Human Milk Oligosaccharides(HMO) are naturally found in the mother’s milk. These are the unique prebiotics that can nourish the baby’s immune system. They also contribute to the growth of an infant's microflora and immune system. Moreover, HMOs biosynthetic production boosts the demand because of function benefits which can be used as additives in infant formula and other dietary products.  

Due to COVID-19, the industries have significantly impacted growth. In a brief period, industries faced severe workforce crises in production facilities because of lockdowns and other restrictions. Human Milk Oligosaccharides (HMO) are the practical components that bring out from human breast milk and function as nutrients for the neurological development of new-born. Therefore, the rising demand for oligosaccharides applications in infant formula specifies the growth of the Human Milk Oligosaccharides (HMO) Market.  

For Additional List and Detail Information on Key Players, Send Your Request for Sample Report Brochure @ https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-sample

What is New Additions in 2023?

1. More detail segmentation

2. Additional information on company players

3. Customized report and analyst support on request

4. Regional analysis on request

5. Updated research methodology

6. Recent developments in the global and regional market

Human Milk Oligosaccharides Market (HMO): Growth drivers

The changing lifestyle of people due to the rise in preference towards consuming a healthy diet and functional food is the factor in the growing HMO market. Moreover, the mother's inability to provide better nutrition to the infant is another factor supporting the growth of Human Milk Oligosaccharides (HMO) industry sales. The rising population is also one of the reasons to boost the demand for the Human Milk Oligosaccharides industry.

As the number of working women is increasing post the birth of a baby, the mother cannot lactate and provide better nutrition to the growing baby. Because of this, the Human Milk Oligosaccharides (HMO) market is growing rapidly. 

Human Milk Oligosaccharides (HMO) Market: Report Segmentation

Insight by Type

Based on Human Milk Oligosaccharides type 2’FL, it is anticipated that the Human Milk Oligosaccharides (HMO) will lead the market. 2’FL is known for its ability to shield against infectious diseases and prevent toxins and pathogens from adhering to epithelial cells. The vast adoption is collected by this segment in 2021.

Insight by Application

Based on application, it is anticipated that the infant formula segment will lead the global Human Milk Oligosaccharides Market in 2021. During the forecast period, it is also estimated that the Human Milk Oligosaccharides (HMO) Market for functional food and beverages to have significant growth.

Geographical Overview: Human Milk Oligosaccharides (HMO)

Based on geography, the Asia Pacific region is expected to dominate the market. The huge adoption of HMOs is expected in the countries such as India, China, Japan, and others because of the vast consumer base for HMOs derivative products. And the hugely populated countries, like India and China, increase the infant population yearly. Therefore, it is determined in the infant formula market that the rising population, where HMO is treated as an essential ingredient for creating infant foods and other supplements. As a result, the Human Milk Oligosaccharides (HMO) market grows.

Need Discount? Ask Us for Available Discount on " Human Milk Oligosaccharides (HMO) Market " @  https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-discount-pricing

Key Players

The leading players in the global Human Milk Oligosaccharides (HMO) market include Abbott Laboratories, BASF S.E., Biosynth Carbosynth, and Chr. Hansen Holding A/S, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Elicityl S.A., Glycom A/S, Glycosyn, Inbiose NV, Medolac Laboratories, Neolacta Lifesciences Pvt. Ltd, Nestle Health Science, Royal DSM, Royal FrieslandCampina N.V., and ZuChem.

Recent Developments

•          In June 2021, H&H Group, Australia, launched its first kids' supplement, Human Milk Oligosaccharides (HMOs). The product is named ProBOOST + Vit D under the brand name Biostime and can be consumed by kids aged 12 months and above.
•          In April 2020, Kyowa Hakko established a new capability to produce human milk oligosaccharides (HMOs) in Thailand due to the increasing demand worldwide for these health products in the coming years.

Browse Additional Details on " Human Milk Oligosaccharides (HMO) Market " @ https://www.polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market

Human Milk Oligosaccharides (HMO) Market: By Type Outlook

•          2’FL
•          3’FL
•          3’SL
•          6’SL

Human Milk Oligosaccharides (HMO) Market: By Application Outlook

•          Infant Formula
•          Functional Food & Beverage
•          Food Supplements

Human Milk Oligosaccharides (HMO) Market: By Distribution Channel Outlook

•          Hypermarkets & Supermarkets
•          Drug Store or Pharmacy
•          Mass Merchandiser, Departmental Stores
•          Mono-brand Stores
•          Specialty Stores
•          Online Sales Channel

Human Milk Oligosaccharides (HMO) Market: By Region Outlook

•          North America (U.S., Canada)
•          Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
•          Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
•          Latin America (Brazil, Mexico, Argentina)
•          Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Contact Us:

Polaris Market Research

Email: sales@polarismarketresearch.com

Ph: +1-929 297-9727

Web: https://www.polarismarketresearch.com